|
WO2020136683A1
|
|
Adaptation of enterovirus to vero cells and vaccine formulations thereof
|
|
WO2020110154A1
|
|
A chimeric therapeutic vaccine
|
|
WO2020095324A1
|
|
Multivalent glycoconjugates immunogenic compositions
|
|
SG11202007503WA
|
|
A process for enterovirus purification and inactivation and vaccine compositions obtained thereof
|
|
KR20200024895A
|
|
Synthetic polypeptide epitope based vaccine composition
|
|
MA44557A1
|
|
Buffer-free rotavirus vaccine, acidic stable, and low dose volume to administer
|
|
CN108883080A
|
|
Novel muramyl peptide derivative compound, its synthesis and application thereof
|
|
WO2017098529A1
|
|
Novel muramyl peptide derivative compound, synthesis and uses thereof
|
|
AU2016291836A1
|
|
Vaccine compositions
|
|
AU2016290233A1
|
|
Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides
|
|
AU2014338520A1
|
|
A viral vaccine and methods of manufacture thereof
|
|
EP3035957A1
|
|
A bacterial vaccine and methods for manufacture thereof
|
|
CN104487086A
|
|
Non-alcoholic vaccine compositions free from animal- origin and process for preparation thereof
|
|
WO2013168182A2
|
|
Vaccine combinations
|
|
CN104507495A
|
|
Rotavirus vaccine compositions and process for preparing the same
|
|
SG10201607787RA
|
|
Vaccine Composition Comprising An Inactivated Chikungunya Virus Strain
|
|
EP3459562A1
|
|
A combination heptavalent vaccine
|
|
CN103228293A
|
|
Vaccine formulation for prophylaxis and treatment of chandipura virus infections in mammals
|
|
WO2011151835A1
|
|
A novel synergistic pharmaceutical composition for topical applications
|
|
CN102470170A
|
|
Composition useful as rotavirus vaccine and a method therefor
|
